drugset / Trial / NCT06932315
A Study to Evaluate the Safety, Tolerability and Dose-Response Relationship of HRS-9190 in Healthy Subjects
NaSingle-groupOpen-labelTreatment
Summary
This is a single-center, open-label and dose-escalation study to evaluate the safety, tolerability and dose-response relationship of HRS-9190 in healthy adults.
Timeline
- Start
- 2025-04-23
- Primary completion
- 2025-08-13
- Completion
- 2025-08-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HRS-9190 | Unknown | — | — |
Indications
No indication recorded.